Frontiers in Medicine · 2022 · 51 citations · 48 references
Life SciencesBiostatisticsGeneticsDementiaEpidemiologyGenetic EpidemiologyAlzheimer DiseaseDementia Risk FactorsGenetic Risk FactorsGenetic Risk PredictionGenome-wide Association StudiesMendelian RandomizationAlzheimer Disease EpidemiologyAlzheimer Disease RiskFamilial DementiaFamily History Of DementiaFamily-based Genetic EpidemiologyGenetic Epidemiology Of DementiaLow-density Lipoprotein Cholesterol MeasurementTwo-sample Mendelian Randomization
Background: Previous observational studies provided conflicting results on the association between low-density lipoprotein cholesterol (LDL-C) level and the risk of Alzheimer's disease (AD). Objective: We used two-sample Mendelian randomization (MR) study to explore the causal associations between LDL-C level and the risks of individual, paternal, maternal, and family history of AD. Methods: Summary-level genetic data for LDL-C were acquired from results of the UK Biobank GWAS. Corresponding data for paternal, maternal, and family history of AD were obtained from the NHGRI-EBI Catalog of human genome-wide association studies. Data for individual AD were obtained from the MR-Base platform. A two-sample MR study was performed to explore the causal association between LDL-C level and the risks of individual, paternal, maternal, and family history of AD. Results: Genetically predicted LDL-C was positively associated with individual [Odds ratio (OR) = 1.509, 95% confidence interval (CI) = 1.140–1.999; P = 4.0 × 10 −3 ], paternal [OR = 1.109, 95% CI = 1.053–1.168; P = 9.5 × 10 −5 ], maternal [OR = 1.132, 95% CI = 1.070–1.199; P = 2.0 × 10 −5 ], and family history of AD [OR = 1.124, 95% CI = 1.070–1.181; P = 3.7 × 10 −6 ] in inverse variance weighted analysis. After performing weighted median and MR-Egger analysis, consistent results were observed. There was no horizontal pleiotropy in the two-sample MR analysis. Conclusions: High level of LDL-C may increase the risks of both individual and familial AD. Decreasing the LDL-C to a reasonable level may help to reduce the related risk.
48
Joep Perk, Guy De Backer, H. Gohlke et al. · European Heart Journal · 2012 · 8.5K citations · Full text
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo Piepoli, Arno W. Hoes, Stefan Agewall et al. · European Heart Journal · 2016 · 6.5K citations · Full text